Impact of genetic polymorphisms in DNA repair enzymes on drug resistance in lung cancer.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D018849:Controlled Clinical Trials as Topic; D004249:DNA Damage / Q000187:drug effects; D045643:DNA Repair Enzymes / Q000235:genetics* / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
D045643:DNA Repair Enzymes